Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
While it's essential to consider financial factors, the benefits of maintaining optimal B12 levels far outweigh the price tag
Dosage for Weight Loss or Fat Metabolism Updating the MIC-B12 dosage to 2-3 milliliters per injection to usually applying two-three times weekly, may be necessary for persons for weight loss and fat metabolism
Always consult a healthcare provider before starting treatment
It was lethal, until doctors found a way to get B12 into the bloodstream